Caroline Bouzad1, Sandrine Duron2, Aurore Bousquet3, François-Xavier Arnaud4, Laura Valbousquet5, Gabrielle Weber-Donat6, Christophe Teriitehau7, Jacques Baccialone8, Julien Potet9. 1. Radiology Department, Percy Military Teaching Hospital, 101 avenue Henri Barbusse, 92140, Clamart, France. caroline.bouzad@gmail.com. 2. Military Centre for Epidemiology and Public Health (CESPA), GSBdD, 111 avenue de la Corse - Caserne Audéoud, 13007, Marseille-Aubagne, France. duronsandrine@yahoo.fr. 3. Bacteriology Department, Begin Military Teaching Hospital, 69 avenue de Paris, 94160, Saint-Mandé, France. aurorebousquet@yahoo.fr. 4. Radiology Department, Percy Military Teaching Hospital, 101 avenue Henri Barbusse, 92140, Clamart, France. fxa0160@hotmail.com. 5. Radiology Department, Begin Military Teaching Hospital, 69 avenue de Paris, 94160, Saint-Mandé, France. laura.valbousquet@gmail.com. 6. Radiology Department, Percy Military Teaching Hospital, 101 avenue Henri Barbusse, 92140, Clamart, France. weberdonatgabrielle@yahoo.fr. 7. Radiology Department, Percy Military Teaching Hospital, 101 avenue Henri Barbusse, 92140, Clamart, France. cteriitehau@me.com. 8. Radiology Department, Percy Military Teaching Hospital, 101 avenue Henri Barbusse, 92140, Clamart, France. jacques.baccialone@wanadoo.fr. 9. Radiology Department, Percy Military Teaching Hospital, 101 avenue Henri Barbusse, 92140, Clamart, France. potet_julien@yahoo.fr.
Abstract
PURPOSE: To determine the incidence and the risks factors of peripherally inserted central catheter (PICC)-related infectious complications. MATERIALS AND METHODS: Medical charts of every in-patient that underwent a PICC insertion in our hospital between January 2010 and October 2013 were reviewed. All PICC-related infections were recorded and categorized as catheter-related bloodstream infections (CR-BSI), exit-site infections, and septic thrombophlebitis. RESULTS: Nine hundred and twenty-three PICCs were placed in 644 unique patients, mostly male (68.3%) with a median age of 58 years. 31 (3.4%) PICC-related infections occurred during the study period corresponding to an infection rate of 1.64 per 1000 catheter-days. We observed 27 (87.1%) CR-BSI, corresponding to a rate of 1.43 per 1000 catheter-days, 3 (9.7%) septic thrombophlebitis, and 1 (3.2%) exit-site infection. Multivariate logistic regression analysis showed a higher PICC-related infection rate with chemotherapy (odds ratio (OR) 7.2-confidence interval (CI) 95% [1.77-29.5]), auto/allograft (OR 5.9-CI 95% [1.2-29.2]), and anti-coagulant therapy (OR 2.2-95% [1.4-12]). CONCLUSION: Chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing PICC-related infections. CLINICAL ADVANCE: Chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of PICC-associated infections. A careful assessment of these risk factors may be important for future success in preventing PICC-related infections.
PURPOSE: To determine the incidence and the risks factors of peripherally inserted central catheter (PICC)-related infectious complications. MATERIALS AND METHODS: Medical charts of every in-patient that underwent a PICC insertion in our hospital between January 2010 and October 2013 were reviewed. All PICC-related infections were recorded and categorized as catheter-related bloodstream infections (CR-BSI), exit-site infections, and septic thrombophlebitis. RESULTS: Nine hundred and twenty-three PICCs were placed in 644 unique patients, mostly male (68.3%) with a median age of 58 years. 31 (3.4%) PICC-related infections occurred during the study period corresponding to an infection rate of 1.64 per 1000 catheter-days. We observed 27 (87.1%) CR-BSI, corresponding to a rate of 1.43 per 1000 catheter-days, 3 (9.7%) septic thrombophlebitis, and 1 (3.2%) exit-site infection. Multivariate logistic regression analysis showed a higher PICC-related infection rate with chemotherapy (odds ratio (OR) 7.2-confidence interval (CI) 95% [1.77-29.5]), auto/allograft (OR 5.9-CI 95% [1.2-29.2]), and anti-coagulant therapy (OR 2.2-95% [1.4-12]). CONCLUSION: Chemotherapy, auto/allograft, and anti-coagulant therapy are associated with an increased risk of developing PICC-related infections. CLINICAL ADVANCE: Chemotherapy, auto/allograft, and anti-coagulant therapy are important predictors of PICC-associated infections. A careful assessment of these risk factors may be important for future success in preventing PICC-related infections.
Authors: Sheryl McDiarmid; Nicholas Scrivens; Marc Carrier; Elham Sabri; Baldwin Toye; Lothar Huebsch; Dean Fergusson Journal: CMAJ Open Date: 2017-06-30
Authors: Jae Hwan Lee; Eung Tae Kim; Dong Jae Shim; Il Jung Kim; Jong Hyun Byeon; In Joon Lee; Hyun Beom Kim; Young Ju Choi; Jin Hong Lee Journal: PLoS One Date: 2019-03-07 Impact factor: 3.240
Authors: Jae Hwan Lee; Min Uk Kim; Eung Tae Kim; Dong Jae Shim; Il Jung Kim; Jong Hyun Byeon; Hyun Beom Kim Journal: Medicine (Baltimore) Date: 2020-02 Impact factor: 1.817